Skip to content

Study · Non-randomized trial · n = 39 · 2011

1 result

[Efficiency of cerebrolysin in the diabetic polyneuropathy in patients with insulin-dependency diabetes mellitus].

Bogdanov EI, Sakovets TG

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2011

PMID21350421 (opens in a new tab)PepBankPUB-21350421
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In patients with diabetes, the study reported therapeutic effectiveness of Cerebrolysin for diabetic polyneuropathic disorders.

    In plain wordsIn patients with diabetes, the study reported improvement of diabetic nerve disorders with Cerebrolysin.

    Peptide
    Cerebrolysin
    Outcome
    DecreaseDiabetic polyneuropathic disorders
    Study

    n = 39

    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    witch allowed to reveal the considerable therapeutic effectiveness of cerebrolysin in treatment of diabetic polyneuropathic disorders.
    2 context sentences
    Summary · context
    78 patients with clinical features of diabetic polyneuropathy have been examined.
    Summary · context
    39 patients, who took cerebrolysin, compose the basic group, 39 patients, who made up control one, took milgamma.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.